Dydrogesterone: all 41 studies that test it
Page 1 of 1. Open to participants first (5), then studies with results posted, then the rest; newest registration first within each.
- Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone TherapyNot yet recruitingNCT07496294Not applicable
- Study on the Effect of Combined Estrogen and Progestogen Therapy on Endometrial Repair After Induced AbortionRecruitingNCT06546397Phase 1
- Dydrogesterone, Cetrorelix Acetate and Triptorelin in Intra Cytoplasmic Sperm Injection OutcomesRecruitingNCT05972902Phase 3
- Didroxyprogesterone Promotes Natural Pregnancy in Infertile Patients With EndometriosisNot yet recruitingNCT05467852Phase 3
- Oral Dydrogesterone as Luteal Phase Support in Natural Cycle FETRecruitingNCT03859921Phase 3
- Progestin Primed Double Stimulation Protocol Versus Flexible GnRH Antagonist Protocol in Poor RespondersCompletedNCT04537078Phase 3Results posted
- A Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Crinone 8% Intravaginal Progesterone Gel 90 mg Daily for Luteal Support in In-Vitro Fertilization (LOTUS II)CompletedNCT02491437Phase 3Results posted
- A Multicenter Study Comparing the Efficacy, Safety and Tolerability of Oral Dydrogesterone 30 mg Daily Versus Intravaginal Micronized Progesterone Capsules 600 mg Daily for Luteal Support in In-Vitro FertilizationCompletedNCT01850030Phase 3Results posted
- PPOS Protocol Versus GnRH Anatagonist for Expected Normal Responder Patients Undergoing ART : a Randomized Clinical TrialCompletedNCT06868576Phase 3
- PPOS vs GnRH Antagonist in Ovarian Stimulation (ProGanOS Study)Active, not recruitingNCT06378268Not applicable
- Progesterone Primed Protocol Versus GnRH Antagonist in With PCO Undergoing ICSICompletedNCT05951400Phase 2/3
- Comparison of 3 Different Protocols for Preventing Premature Ovulation in Ovarian Stimulation CyclesCompletedNCT05767086Not applicable
- The Rescue of Hormonal Replacement Frozen Embryo Transfer Cycle With Low Serum Progesterone.Status unknownNCT05758064Phase 2/3
- Dydrogesterone-Primed Ovarian Stimulation Protocol Versus Gonadotropin Releasing Hormone Antagonist Protocol in ICSIStatus unknownNCT05751681Not applicable
- Progestin-primed Ovarian Stimulation Protocol Versus GnRH Antagonist Protocol in Polycystic Ovary Syndrome Patients Undergoing IVF/ICSI CyclesStatus unknownNCT05112692Not applicable
- Oral Progesterone for Prevention of Miscarriage in Threatened AbortionCompletedNCT04788108Phase 4
- Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer CyclesCompletedNCT04758871Phase 4
- Comparison of the Euploid Rate of Blastocyst Between PPOS and GnRH Antagonist Protocol in Patients Undergoing PGT-ACompletedNCT04414748Phase 3
- Addition of Dydrogesterone to the Luteal Phase Support After Fresh Embryo TransferStatus unknownNCT04408144Not applicable
- The Effect of Dydrogesterone on Sexual Function in Women With EndometriosisCompletedNCT04287205Not applicable
- Oral Dydrogesterone vs. Micronized Vaginal Progesterone for Luteal Phase Support in Frozen-thawed Embryo Transfer CyclesStatus unknownNCT04124913Phase 4
- Progesterone Versus Progesterone Plus Dydrogesterone in FETCompletedNCT03998761Not applicable
- Luteal Support in Frozen-Thawed Embryo Transfer CyclesCompletedNCT03948022Phase 4
- Oral Dydrogesterone in the Management of Preterm LaborCompletedNCT03935152Phase 4
- Oral Dydrogesterone vs. Vaginal Micronized Progesterone for Luteal Phase Support in Frozen-thawed Embryo TransferStatus unknownNCT03832699Not applicable
- Dydrogesterone in the Treatment of Endometrial PolypsCompletedNCT03790215Phase 4
- Comparison of the Live Birth Rate Between the PPOS and the GnRH Antagonist Protocol in Patients Undergoing IVFTerminatedNCT03680053Not applicable
- MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without AtypiaCompletedNCT03675139Phase 3
- Different Types of Progesterone in the Prevention of Preterm LaborStatus unknownNCT03537287Phase 2
- The Efficacy of Progestins in Treatment of Functional Ovarian CystStatus unknownNCT03456570Early Phase 1
- Progesterone to Prevent Preterm DeliveryStatus unknownNCT03428685Phase 2/3
- The Efficacy of Estrogen Therapy Against Adhesion Reformation After Hysteroscopic AdhesiolysisStatus unknownNCT03351205Not applicable
- Comparing the Efficacy of Two Methods in the Prevention of Adhesion Reformation After Hysteroscopic AdhesiolysisStatus unknownNCT03346317Not applicable
- Progesterone and Doppler in Recurrent AbortionStatus unknownNCT03267771Phase 4
- Efficacy of Oral Progesterone and Vaginal Progesterone After Tocolytic Therapy in Threatened Preterm LaborCompletedNCT02989519Phase 3
- Oral Progestogen Supplementation in the Prevention of Recurrent Uterine Contraction in Preterm LaborCompletedNCT02262481Not applicable
- Randomized Double-blind Controlled Trial of Use of Dydrogesterone in Threatened MiscarriageCompletedNCT02128685Phase 3
- The Effect of Different Types of Progestin on Sleeping of Menopausal WomenCompletedNCT02086032Not applicable
- Dydrogesterone Versus Intravaginal Progesterone in the Luteal Phase SupportCompletedNCT01178931Not applicable
- Habitual Abortion Study: Oral Dydrogesterone Treatment During Pregnancy in Women With Recurrent MiscarriageCompletedNCT00193674Phase 3
- Endometrial Safety Study of a 0.5 mg Estradiol and 2.5 mg Dydrogesterone CombinationCompletedNCT00160316Phase 3